Beijing Succeeder Technology Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

1.10

Vol. 1Y

—

Shs. 5Y

-0.41%

Rev. 5Y

3.46%

Div Yld LY

—

Div Yld TTM

—

Revenues

264m

-13.80%

Net income

90m

-20.71%

CFO

79m

-35.44%

Dividend

Jun 04, 20260.26 /sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Beijing Succeeder Technology Inc. specializes in the development, production, and distribution of in-vitro diagnostic (IVD) products, serving markets both domestically within China and internationally. The company provides a comprehensive portfolio of diagnostic equipment, including coagulation analyzers and their associated reagents, blood rheology analyzers, erythrocyte sedimentation rate (ESR) analyzers, and platelet aggregation analyzers. Established in 2003, its main operational base is located in Beijing, China.

URL

http://www.succeeder.com.cn

IPO date

Aug 06, 2020

Employees

Domiciled in

Incorporated in

Valuation

Latest on right Latest on left

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT